Cost-Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study.
Seijas-Amigo J, Mauriz-Montero MJ, Suarez-Artime P, Gayoso-Rey M, Reyes-Santías F, Estany-Gestal A, Casas-Martínez A, González-Freire L, Rodriguez-Vazquez A, Pérez-Rodriguez N, Villaverde-Piñeiro L, Castro-Rubinos C, Espino-Paisán E, Cordova-Arevalo O, Rodriguez-Penas D, Cardeso-Paredes B, Ribeiro-Ferreiro M, Rodríguez-Mañero M, Cordero A, González-Juanatey JR, Memogal Investigators.
Seijas-Amigo J, et al. Among authors: cordero a.
Diseases. 2024 Oct 5;12(10):244. doi: 10.3390/diseases12100244.
Diseases. 2024.
PMID: 39452487
Free PMC article.